Research progress of natural compounds in anti-liver fibrosis by affecting autophagy of hepatic stellate cells

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1573-4978

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Research progress of natural compounds in anti-liver fibrosis by affecting autophagy of hepatic stellate cells ; volume:48 ; number:2 ; day:20 ; month:2 ; year:2021 ; pages:1915-1924 ; date:2.2021
Molecular biology reports ; 48, Heft 2 (20.2.2021), 1915-1924, 2.2021

Creator: Shu, Yongxiang
Liu, Xuyou
Huang, Haifeng
Wen, Qi
Shu, Jianchang

Contributor: SpringerLink (Online service)

DOI: 10.1007/s11033-021-06171-w

URN: urn:nbn:de:101:1-2021041621484901274334

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:44 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Shu, Yongxiang
Liu, Xuyou
Huang, Haifeng
Wen, Qi
Shu, Jianchang
SpringerLink (Online service)

Other Objects (12)

Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis

Bone morphogenetic protein 13 in hepatic stellate cells and hepatic fibrosis

Targeting glutamine metabolism in hepatic stellate cells alleviates liver fibrosis

Quercetin prevents hepatic fibrosis by inhibiting hepatic stellate cell activation and reducing autophagy via the TGF-β1/Smads and PI3K/Akt pathways

Transcriptional factor ATF3 promotes liver fibrosis via activating hepatic stellate cells

Role of PDLIM1 in hepatic stellate cell activation and liver fibrosis progression

Dihydromyricetin ameliorates liver fibrosis via inhibition of hepatic stellate cells by inducing autophagy and natural killer cell-mediated killing effect

Methyl Helicterate Inhibits Hepatic Stellate Cell Activation Through Modulation of Apoptosis and Autophagy

Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells

miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression

Hepatic stellate cells: central modulators of hepatic carcinogenesis

Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis

Bone morphogenetic protein 13 in hepatic stellate cells and hepatic fibrosis

Targeting glutamine metabolism in hepatic stellate cells alleviates liver fibrosis

Quercetin prevents hepatic fibrosis by inhibiting hepatic stellate cell activation and reducing autophagy via the TGF-β1/Smads and PI3K/Akt pathways

Transcriptional factor ATF3 promotes liver fibrosis via activating hepatic stellate cells

Role of PDLIM1 in hepatic stellate cell activation and liver fibrosis progression

Dihydromyricetin ameliorates liver fibrosis via inhibition of hepatic stellate cells by inducing autophagy and natural killer cell-mediated killing effect

Methyl Helicterate Inhibits Hepatic Stellate Cell Activation Through Modulation of Apoptosis and Autophagy

Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells

miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression

Hepatic stellate cells: central modulators of hepatic carcinogenesis

Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis

Bone morphogenetic protein 13 in hepatic stellate cells and hepatic fibrosis

Targeting glutamine metabolism in hepatic stellate cells alleviates liver fibrosis

Quercetin prevents hepatic fibrosis by inhibiting hepatic stellate cell activation and reducing autophagy via the TGF-β1/Smads and PI3K/Akt pathways

Transcriptional factor ATF3 promotes liver fibrosis via activating hepatic stellate cells

Role of PDLIM1 in hepatic stellate cell activation and liver fibrosis progression

Dihydromyricetin ameliorates liver fibrosis via inhibition of hepatic stellate cells by inducing autophagy and natural killer cell-mediated killing effect

Methyl Helicterate Inhibits Hepatic Stellate Cell Activation Through Modulation of Apoptosis and Autophagy

Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells

miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression

Hepatic stellate cells: central modulators of hepatic carcinogenesis

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Research progress of natural compounds in anti-liver fibrosis by affecting autophagy of hepatic stellate cells

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis

Bone morphogenetic protein 13 in hepatic stellate cells and hepatic fibrosis

Targeting glutamine metabolism in hepatic stellate cells alleviates liver fibrosis

Quercetin prevents hepatic fibrosis by inhibiting hepatic stellate cell activation and reducing autophagy via the TGF-β1/Smads and PI3K/Akt pathways

Transcriptional factor ATF3 promotes liver fibrosis via activating hepatic stellate cells

Role of PDLIM1 in hepatic stellate cell activation and liver fibrosis progression

Dihydromyricetin ameliorates liver fibrosis via inhibition of hepatic stellate cells by inducing autophagy and natural killer cell-mediated killing effect

Methyl Helicterate Inhibits Hepatic Stellate Cell Activation Through Modulation of Apoptosis and Autophagy

Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells

miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression

Hepatic stellate cells: central modulators of hepatic carcinogenesis

Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis

Bone morphogenetic protein 13 in hepatic stellate cells and hepatic fibrosis

Targeting glutamine metabolism in hepatic stellate cells alleviates liver fibrosis

Quercetin prevents hepatic fibrosis by inhibiting hepatic stellate cell activation and reducing autophagy via the TGF-β1/Smads and PI3K/Akt pathways

Transcriptional factor ATF3 promotes liver fibrosis via activating hepatic stellate cells

Role of PDLIM1 in hepatic stellate cell activation and liver fibrosis progression

Dihydromyricetin ameliorates liver fibrosis via inhibition of hepatic stellate cells by inducing autophagy and natural killer cell-mediated killing effect

Methyl Helicterate Inhibits Hepatic Stellate Cell Activation Through Modulation of Apoptosis and Autophagy

Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells

miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression

Hepatic stellate cells: central modulators of hepatic carcinogenesis

Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis

Bone morphogenetic protein 13 in hepatic stellate cells and hepatic fibrosis

Targeting glutamine metabolism in hepatic stellate cells alleviates liver fibrosis

Quercetin prevents hepatic fibrosis by inhibiting hepatic stellate cell activation and reducing autophagy via the TGF-β1/Smads and PI3K/Akt pathways

Transcriptional factor ATF3 promotes liver fibrosis via activating hepatic stellate cells

Role of PDLIM1 in hepatic stellate cell activation and liver fibrosis progression

Dihydromyricetin ameliorates liver fibrosis via inhibition of hepatic stellate cells by inducing autophagy and natural killer cell-mediated killing effect

Methyl Helicterate Inhibits Hepatic Stellate Cell Activation Through Modulation of Apoptosis and Autophagy

Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells

miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression

Hepatic stellate cells: central modulators of hepatic carcinogenesis

Related objects

Reset password